Gf-Fund-Management-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf-Fund-Management-Co
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions • $4.3B total value
Manager:
Search and click to pin securities to the top
Page 29 of 34
590717401
Shares:817
Value:$10.2K
% of Portfolio:0.0% ($10.2K/$4.3B)
UNIVERSAL HEALTH REALTY INCOME TRUST
Shares:247
Value:$10.1K
% of Portfolio:0.0% ($10.1K/$4.3B)
Oric Pharmaceuticals, Inc.
Shares:1.8K
Value:$10.1K
% of Portfolio:0.0% ($10.1K/$4.3B)
SIGA TECHNOLOGIES INC
Shares:1.8K
Value:$10.0K
% of Portfolio:0.0% ($10.0K/$4.3B)
Tourmaline Bio, Inc.
Shares:656
Value:$10.0K
% of Portfolio:0.0% ($10.0K/$4.3B)
Erasca, Inc.
Shares:7.2K
Value:$9.9K
% of Portfolio:0.0% ($9.9K/$4.3B)
Verve Therapeutics, Inc.
Shares:2.2K
Value:$9.9K
% of Portfolio:0.0% ($9.9K/$4.3B)
Sana Biotechnology, Inc.
Shares:5.7K
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$4.3B)
CorMedix Inc.
Shares:1.6K
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$4.3B)
Community Healthcare Trust Inc
Shares:527
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$4.3B)
Farmland Partners Inc.
Shares:858
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$4.3B)
BICYCLE THERAPEUTICS PLC
Shares:1.1K
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$4.3B)
EyePoint Pharmaceuticals, Inc.
Shares:1.7K
Value:$9.5K
% of Portfolio:0.0% ($9.5K/$4.3B)
Rapport Therapeutics, Inc.
Shares:936
Value:$9.4K
% of Portfolio:0.0% ($9.4K/$4.3B)
ALEXANDERS INC
Shares:44
Value:$9.2K
% of Portfolio:0.0% ($9.2K/$4.3B)
Oruka Therapeutics, Inc.
Shares:896
Value:$9.2K
% of Portfolio:0.0% ($9.2K/$4.3B)
Altimmune, Inc.
Shares:1.8K
Value:$9.1K
% of Portfolio:0.0% ($9.1K/$4.3B)
REGENXBIO Inc.
Shares:1.3K
Value:$9.1K
% of Portfolio:0.0% ($9.1K/$4.3B)
SAUL CENTERS, INC.
Shares:250
Value:$9.0K
% of Portfolio:0.0% ($9.0K/$4.3B)
Stoke Therapeutics, Inc.
Shares:1.4K
Value:$9.0K
% of Portfolio:0.0% ($9.0K/$4.3B)